Cardiotoxicity

Yeh, a professor of cardiology at the MD Anderson Cancer Center at the University of Texas, reported on June 29th at Circulation (20041093122) that cancer treatments include the most commonly used chemotherapeutics and the latest biological and targeted therapies. May cause damage to the patient's heart and even cause death. However, for the cardiotoxicity of anticancer drugs, many physicians have not adequately monitored them and have not taken corresponding preventive measures. This large-scale study led by Yeh summarizes the 30 years of experience at MD Anderson Cancer Center and a large number of recent studies on the cardiotoxicity of anticancer drugs, reviewing in detail the cardiac complications of anticancer treatment and their prevention methods. Yeh said the findings are significant because physicians and patients may not know what cardiotoxicity can be caused by anti-cancer treatments and many of them are preventable. He said that cardiotoxicity is actually more harmful to many cancer survivors than cancer recurrence. In this study, the researchers reviewed 29 anticancer drugs and found that all types of anticancer drugs may have cardiotoxicity without exception. The heart seems particularly sensitive to the toxicity of anticancer drugs.